Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia group.

Maurizio Del Pinto,Francesco Amico,Natale Brunetti,Pasquale Caldarola,Stefano Carugo,Claudio Cavallini, Antonello D'Andrea,Francesco Fedele,Ciro Mauro,Patrizia Noussan,Leonardo Paloscia,Francesco Prati,Pierpaolo Tarzia,Maurizio Tespili, Lucia Barbieri, Pierangelo Basso,Andrea Buono, Alberto D'Alleva,Simona Giubilato, Mario Iannacone,Fabio Ferrante, Giuseppina Granata,Riccardo Ieva, Alfredo Madrid,Maria Teresa Mallus,Ercole Tagliamonte

International journal of cardiology. Cardiovascular risk and prevention（2023）

引用 0|浏览28

暂无评分

摘要

Our analysis, though numerically and methodologically limited, suggests that management of cholesterolaemia and achievement of LDL-C targets are largely suboptimal and need significant improvement to comply with the lipid-lowering guidelines for very high CV risk patients. Earlier high intensity statin combination therapy should be encouraged in patients with high residual risk.

查看译文

关键词

Acute coronary syndrome,Follow-up,LDL cholesterol,Statin,Target

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要